Telix And Ekalia, IBA-Framatome Joint Venture, Collaborate On US Astatine-211 Production, Securing Priority Isotope Access For TLX102-Tx Glioblastoma Pipeline
Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT).Secures long-term,
Telix found a reliable way to get a rare radioactive material for cancer medicine. This means the company can keep developing its new glioblastoma drug without supply problems.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.